ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.8K |
949K |
1 |
09:00 |
09:00 |
ASX - By Stock
|
2.8K
|
949K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
701 |
255K |
109 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
701
|
255K
|
109
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 cGMP Manufacturing Complete
|
|
Mason14
|
76 |
21K |
70 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
76
|
21K
|
70
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 cGMP Manufacturing Complete
|
|
Mason14
|
76 |
21K |
136 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
76
|
21K
|
136
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
351 |
92K |
82 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
351
|
92K
|
82
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene shows potent anticancer activity in AML models
|
|
Mason14
|
85 |
28K |
67 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
85
|
28K
|
67
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
351 |
92K |
190 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
351
|
92K
|
190
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
351 |
92K |
139 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
351
|
92K
|
139
|
|
ASX - By Stock
|
SFX |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Mason14
|
21 |
8.6K |
11 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
21
|
8.6K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
22K |
10M |
8 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
22K
|
10M
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
22K |
10M |
9 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
22K
|
10M
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.8K |
949K |
99 |
12/11/23 |
12/11/23 |
ASX - By Stock
|
2.8K
|
949K
|
99
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
Mason14
|
231 |
62K |
42 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
231
|
62K
|
42
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
Mason14
|
231 |
62K |
53 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
231
|
62K
|
53
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
Mason14
|
231 |
62K |
74 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
231
|
62K
|
74
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Mason14
|
20K |
6.8M |
29 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
20K
|
6.8M
|
29
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
Mason14
|
231 |
62K |
84 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
231
|
62K
|
84
|
|
ASX - By Stock
|
RAC |
Re:
ASH2023 - Sheba 2.0
|
|
Mason14
|
153 |
48K |
149 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
153
|
48K
|
149
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
Mason14
|
1.0K |
627K |
1 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
1.0K
|
627K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Next cohort reached in IV arms of CF33-hNIS (VAXINIA) study
|
|
Mason14
|
102 |
42K |
10 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
102
|
42K
|
10
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
10K |
3.6M |
89 |
10/09/23 |
10/09/23 |
General
|
10K
|
3.6M
|
89
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
22K |
10M |
1 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
22K
|
10M
|
1
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
Mason14
|
1.0K |
627K |
16 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
1.0K
|
627K
|
16
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
Mason14
|
1.0K |
627K |
31 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
1.0K
|
627K
|
31
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
Mason14
|
1.0K |
627K |
13 |
23/04/23 |
23/04/23 |
ASX - By Stock
|
1.0K
|
627K
|
13
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
Mason14
|
1.0K |
627K |
20 |
22/04/23 |
22/04/23 |
ASX - By Stock
|
1.0K
|
627K
|
20
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
22K |
10M |
7 |
08/04/23 |
08/04/23 |
ASX - By Stock
|
22K
|
10M
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
22K |
10M |
7 |
08/04/23 |
08/04/23 |
ASX - By Stock
|
22K
|
10M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases cardioprotection market potential data
|
|
Mason14
|
239 |
93K |
19 |
08/04/23 |
08/04/23 |
ASX - By Stock
|
239
|
93K
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases cardioprotection market potential data
|
|
Mason14
|
239 |
93K |
142 |
07/04/23 |
07/04/23 |
ASX - By Stock
|
239
|
93K
|
142
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases cardioprotection market potential data
|
|
Mason14
|
239 |
93K |
108 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
239
|
93K
|
108
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases cardioprotection market potential data
|
|
Mason14
|
239 |
93K |
120 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
239
|
93K
|
120
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases cardioprotection market potential data
|
|
Mason14
|
239 |
93K |
108 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
239
|
93K
|
108
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases cardioprotection market potential data
|
|
Mason14
|
239 |
93K |
160 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
239
|
93K
|
160
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Leadership Changes
|
|
Mason14
|
559 |
174K |
140 |
01/04/23 |
01/04/23 |
ASX - By Stock
|
559
|
174K
|
140
|
|
ASX - By Stock
|
SFX |
Re:
Ann: Investor Presentation - Equity Raising & Growth Strategy
|
|
Mason14
|
38 |
18K |
3 |
04/03/23 |
04/03/23 |
ASX - By Stock
|
38
|
18K
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
10K |
3.6M |
108 |
12/11/22 |
12/11/22 |
General
|
10K
|
3.6M
|
108
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene Improves Immune Therapy Treatment of Melanoma
|
|
Mason14
|
91 |
32K |
117 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
91
|
32K
|
117
|
|
ASX - By Stock
|
RAC |
Re:
RAC Primer
|
|
Mason14
|
521 |
192K |
177 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
521
|
192K
|
177
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Mason14
|
20K |
6.8M |
156 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
20K
|
6.8M
|
156
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
10K |
3.6M |
45 |
16/05/22 |
16/05/22 |
General
|
10K
|
3.6M
|
45
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
10K |
3.6M |
96 |
16/05/22 |
16/05/22 |
General
|
10K
|
3.6M
|
96
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Receives Governance Approval for AML EMD & MDS Trial
|
|
Mason14
|
96 |
37K |
191 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
96
|
37K
|
191
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Clarification Announcement
|
|
Mason14
|
407 |
163K |
56 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
407
|
163K
|
56
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Mason14
|
20K |
6.8M |
50 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
20K
|
6.8M
|
50
|
|
ASX - By Stock
|
SHP |
Re:
7.5c SP -> $1.11 SP Target (Largest Potash Deposit in West-Europe) $30M MC
|
|
Mason14
|
2.1K |
605K |
24 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
2.1K
|
605K
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Science Series CHECKvacc
|
|
Mason14
|
131 |
57K |
15 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
131
|
57K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
$2 and $1 targets... Yucky wouldn't touch it with yours
|
|
Mason14
|
438 |
174K |
52 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
438
|
174K
|
52
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
22K |
10M |
35 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
22K
|
10M
|
35
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
22K |
10M |
27 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
22K
|
10M
|
27
|
|